Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.

Medicine - 1 Mar 2016

Hsiao Liang-Tsai, Wang Hao-Yuan, Yang Ching-Fen, Chiou Tzeon-Jye, Gau Jyh-Pyng, Yu Yuan-Bin, Liu Hsiao-Ling, Chang Wen-Chun, Chen Po-Min, Tzeng Cheng-Hwai, Chan Yu-Jiun, Yang Muh-Hwa, Liu Jin-Hwang, Huang Yi-Hsiang

Abstract excerpt

Hepatitis B virus (HBV) reactivation has been noted in HBV surface antigen (HBsAg)-seronegative patients with CD20 B-cell non-Hodgkin lymphoma (NHL) undergoing rituximab treatment. Clinically, hepatitis flares are usually associated with the reappearance of HBsAg (reverse seroconversion of HBsAg, HBV-RS). It is unclear whether human genetic factors are related to rituximab-associated HBV reactivation....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Interleukin-4

Share to Lymphoma, Non-Hodgkin

Share to Recurrence

Share to Regression Analysis

Share to Rituximab

Source

Open in PubMed Open full text

Identifiers

PMID: 26986131
DOI: 10.1097/MD.0000000000003064
PMCID: PMC4839912

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.PMID 26986131Read ↗

Association of single nucleotide polymorphisms in immune-related genes with spontaneous HBsAg seroconversion: A systematic review and meta-analysis.Semantic proximity Read ↗

Host cytokine genetic polymorphisms in a selected population of persons living with hepatitis B virus infection in the central region of Ghana.Semantic proximity Read ↗

Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.Semantic proximity Read ↗

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.Semantic proximity Read ↗

Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.Semantic proximity Read ↗

Correlation of FcγRIIIa Polymorphisms to the Response of Rituximab in Thai Patients with Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

Influence of single nucleotide polymorphisms of cytokine genes on anti-HBs antibody production after hepatitis B vaccination in a Japanese young adult population.Semantic proximity Read ↗

Do hepatitis C Virus genotypes influence liver dysfunction following rituximab-containing regimens in patients with diffuse large B cell lymphoma?Semantic proximity Read ↗

Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.Semantic proximity Read ↗

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.Semantic proximity Read ↗

Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.Semantic proximity Read ↗

The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.